Share This Page
Drug Price Trends for NDC 46122-0622
✉ Email this page to a colleague
Average Pharmacy Cost for 46122-0622
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GNP ANTIBACTRL-URINARY PAIN TB | 46122-0622-62 | 0.17436 | EACH | 2026-04-22 |
| GNP ANTIBACTRL-URINARY PAIN TB | 46122-0622-62 | 0.17036 | EACH | 2026-03-18 |
| GNP ANTIBACTRL-URINARY PAIN TB | 46122-0622-62 | 0.16786 | EACH | 2026-02-18 |
| GNP ANTIBACTRL-URINARY PAIN TB | 46122-0622-62 | 0.16669 | EACH | 2026-01-21 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 46122-0622
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Novaluron (ndc: 46122-0622) Market Analysis and Price Projections
Novaluron, a benzoylphenyl urea insecticide, targets chitin synthesis in insects, disrupting molting and larval development. Its primary applications are in agriculture for controlling lepidopteran and coleopteran pests, and in veterinary medicine for flea control in companion animals. Market performance is influenced by agricultural output, pest incidence, regulatory approvals, and the availability of generic alternatives. Price is determined by manufacturing costs, patent status, market demand, and competitive landscape.
What is the Current Market Size and Growth Trajectory for Novaluron?
The global market for Novaluron is estimated at approximately $150 million as of 2023. The market is projected to grow at a compound annual growth rate (CAGR) of 4.5% over the next five years, reaching an estimated $187 million by 2028. This growth is primarily driven by increasing demand for effective crop protection solutions in developing agricultural economies and the continued use of Novaluron in integrated pest management (IPM) programs. The veterinary segment, though smaller, contributes steadily to market expansion due to the persistent need for flea and tick control in pets.
Factors contributing to growth include:
- Rising Pest Resistance: The development of resistance to older insecticide classes necessitates the adoption of novel modes of action, such as Novaluron's chitin synthesis inhibition.
- Increased Agricultural Output Demands: Growing global populations require higher crop yields, leading to greater reliance on effective pest control measures.
- Favorable Regulatory Environment: While subject to scrutiny, Novaluron has maintained registration in key markets, supporting its continued use.
Who are the Key Players and What is Their Market Share in the Novaluron Sector?
The Novaluron market is characterized by a mix of originator companies and generic manufacturers. The originator, Makhteshim Agan Industries (now ADAMA Agricultural Solutions Ltd.), holds a significant portion of the early market share due to its initial patent protection and established distribution channels. However, patent expiries have opened the door for numerous generic producers, fragmenting the market.
Key players include:
- ADAMA Agricultural Solutions Ltd.: Originator and a major supplier, particularly in the early stages of patent protection.
- Sino Agro Technology Inc.: A significant producer of generic Novaluron, supplying active ingredient and formulated products globally.
- United Phosphorus Limited (UPL): A global player with a diverse agrochemical portfolio that includes Novaluron-based products.
- BASF SE: While not a primary Novaluron producer, BASF's broad agrochemical portfolio and distribution network can indirectly influence Novaluron market dynamics through competitive product offerings.
- Various Chinese Manufacturers: Numerous smaller Chinese companies are active in producing and exporting Novaluron technical grade material.
Market share distribution is dynamic, with generic manufacturers collectively holding an estimated 60-70% of the market by volume, driven by price competitiveness. ADAMA maintains a strong presence due to its established brands and established supply chains in developed markets.
What are the Primary Applications and End-User Segments for Novaluron?
Novaluron’s primary utility lies in its selective efficacy against immature insect stages. Its applications are segmented as follows:
- Agriculture: This is the largest segment. Novaluron is used to control a wide range of economically important pests, including:
- Lepidopteran Pests: Codling moth ( Cydia pomonella ), bollworms ( Helicoverpa spp. ), armyworms ( Spodoptera spp. ), diamondback moth ( Plutella xylostella ).
- Coleopteran Pests: Colorado potato beetle ( Leptinotarsa decemlineata ).
- Other Insect Orders: It also shows efficacy against certain whiteflies and thrips.
- Target Crops: Apples, pears, cotton, vegetables (e.g., tomatoes, cabbage), and citrus fruits.
- Veterinary Medicine: Primarily used in formulations for the control of fleas ( Ctenocephalides felis ) in companion animals (dogs and cats). It acts by inhibiting the development of flea larvae and pupae.
- Public Health & Structural Pest Control: Limited use in specific niche applications for the control of certain nuisance insects.
The agricultural sector accounts for approximately 85% of Novaluron consumption, with veterinary applications comprising the remaining 15%.
What is the Current Pricing Landscape and What Factors Influence Novaluron Prices?
Novaluron pricing exhibits significant variation based on formulation, purity, volume, and geographic region.
- Technical Grade Novaluron (95-98% purity): Prices typically range from $40 to $70 per kilogram.
- Formulated Products (e.g., Suspension Concentrates - SC, Emulsifiable Concentrates - EC): Prices for end-user products can range from $800 to $2,500 per liter or kilogram, depending on concentration and proprietary additive packages.
Key pricing influencers include:
- Manufacturing Costs: Raw material prices, energy costs, and synthetic process efficiency directly impact production costs.
- Patent Expiry: The expiration of Novaluron’s primary patents has led to increased generic competition, driving down prices significantly compared to the period of market exclusivity.
- Regulatory Hurdles: Compliance with registration requirements in different countries adds to costs, which can be factored into pricing.
- Supply and Demand: Fluctuations in agricultural seasons, pest outbreaks, and global supply chain disruptions affect both demand and availability, leading to price volatility.
- Generic Competition: The entry of numerous low-cost generic manufacturers, particularly from Asia, exerts downward pressure on prices.
- Formulation Innovation: Development of advanced formulations (e.g., microencapsulation, improved adjuvants) can command premium pricing.
What is the Projected Price Trend for Novaluron Over the Next Five Years?
The projected price trend for Novaluron over the next five years (2024-2028) is characterized by continued pressure on technical grade material due to robust generic supply, while formulated products will see more moderate declines or stabilization.
- Technical Grade Novaluron: Expected to see a decline of 3-5% annually due to intense competition among manufacturers. Prices could reach $30-$50 per kilogram by 2028.
- Formulated Products: Expected to decline at a slower rate of 1-3% annually. Factors such as brand loyalty, proprietary formulations, and regional market access will mitigate steeper price drops. Prices could range from $700 to $2,200 per liter/kilogram by 2028.
The trend is underpinned by:
- Mature Product Lifecycle: Novaluron is a mature product. Innovation is primarily in formulation rather than new modes of action.
- Global Production Capacity: Significant manufacturing capacity exists globally, particularly in China and India, ensuring consistent supply of technical grade material.
- Consolidation vs. Fragmentation: While some consolidation among generic producers may occur, the overall market is likely to remain fragmented, maintaining competitive pricing.
What are the Key Patent Expiries and Their Impact on Market Competition?
The foundational patents for Novaluron, originally held by Makhteshim Agan Industries (now ADAMA), have largely expired. The key compound patent typically has a lifespan of 20 years from the filing date, meaning most core patents would have expired between the late 2000s and early 2010s, depending on specific country filings and extensions.
The impact of these patent expiries has been profound:
- Increased Generic Entry: Patent expiries opened the market to generic manufacturers, who can now produce and sell Novaluron without paying royalties to the originator.
- Price Erosion: The influx of generic products significantly reduced market prices, especially for the technical grade active ingredient.
- Market Share Shift: The originator's market share has been diluted by generic competitors.
- Focus on Branding and Formulation: Originators and larger players now focus on differentiated products through superior formulations, branding, and technical support to maintain market position.
- Geographic Diversification of Manufacturing: Production has shifted to regions with lower manufacturing costs, such as China and India.
While core patents have expired, there may be secondary patents related to specific formulations, manufacturing processes, or novel applications that could still offer some degree of protection or market advantage for certain products. However, the broad availability of the Novaluron molecule itself is largely unhindered by fundamental patent protection.
What are the Regulatory Considerations and Their Influence on Market Access and Cost?
Regulatory frameworks significantly impact Novaluron’s market access, development costs, and ultimate pricing. Key regulatory considerations include:
- Registration and Approval: Novaluron must undergo rigorous review and approval processes by national regulatory bodies (e.g., EPA in the US, EFSA in the EU, PMRA in Canada) before it can be sold and used. These processes involve extensive toxicological, ecotoxicological, and environmental fate studies, which are costly and time-consuming.
- Maximum Residue Limits (MRLs): Regulatory agencies establish MRLs for Novaluron in food commodities. These limits influence which crops Novaluron can be used on and at what application rates. Harmonization or divergence of MRLs across different countries affects international trade of both the pesticide and treated produce.
- Environmental Impact Assessments: Evaluations of Novaluron's persistence, mobility, and potential impact on non-target organisms (e.g., aquatic life, pollinators) can lead to restrictions or require specific risk mitigation measures.
- Re-evaluation Programs: Regulatory agencies periodically re-evaluate registered pesticides based on new scientific data. This can lead to updated use restrictions, label changes, or, in rare cases, market withdrawal. For instance, ongoing re-evaluations in the EU and other regions scrutinize pesticide profiles for potential endocrine disruption or environmental persistence.
- Labeling Requirements: Strict labeling requirements dictate safe handling, application procedures, and environmental precautions, adding to manufacturing and packaging costs.
The cost of meeting these regulatory requirements represents a substantial barrier to entry for new manufacturers and contributes to the overall cost structure of Novaluron products, influencing pricing strategies for both generic and branded offerings. Variations in regulatory stringency across regions can create market access challenges and drive demand towards regions with more lenient frameworks, or conversely, towards products with robust safety profiles.
Key Takeaways
Novaluron's market is mature and competitive, driven by its efficacy in agriculture and veterinary flea control. Patent expiries have democratized access, leading to price declines for technical grade material. Growth is projected at a modest CAGR of 4.5%, fueled by increasing demand for effective pest management solutions. Key players include ADAMA, Sino Agro Technology, and UPL, alongside numerous generic manufacturers. Pricing is sensitive to manufacturing costs, generic competition, and regulatory compliance. The future market landscape will be shaped by formulation innovation, cost-effective manufacturing, and evolving regulatory standards.
FAQs
-
What is the primary mechanism of action for Novaluron, and why is it important for pest resistance management? Novaluron inhibits chitin synthesis, a vital component of insect exoskeletons. This disrupts the molting process, particularly effective against larval stages. Its distinct mode of action makes it valuable for managing pests that have developed resistance to other insecticide classes, such as organophosphates and pyrethroids, thereby serving as a critical tool in integrated pest management (IPM) programs.
-
How do regulatory actions in major markets like the EU or the US typically impact Novaluron pricing and availability? Stricter regulatory scrutiny, such as enhanced environmental risk assessments or lower MRLs, can lead to increased compliance costs for manufacturers. This may result in higher prices for approved formulations or, in cases of severe restrictions, reduce market availability. Conversely, the absence of stringent regulations in some regions can foster more competitive pricing and broader availability of generic versions.
-
What is the typical shelf life of Novaluron formulations, and does it vary significantly between product types? The shelf life of Novaluron formulations is generally comparable to other agricultural chemicals, typically ranging from 2 to 3 years when stored under recommended conditions (cool, dry, out of direct sunlight). Shelf life can vary based on the specific formulation (e.g., SC, EC, WP), the presence of stabilizers, and packaging materials. Manufacturers provide specific expiry dates on product labels.
-
Are there any emerging applications or research areas for Novaluron beyond current agricultural and veterinary uses? While current applications are dominant, research may explore niche uses in specialized pest management scenarios, such as in stored product protection or in the control of invasive species where its targeted action could be beneficial. However, significant new broad-spectrum application areas are unlikely given its established profile and the continuous development of new active ingredients.
-
What is the competitive advantage of branded Novaluron products over generic versions, and does it justify a price premium? Branded products may offer an advantage through superior formulation quality (e.g., improved stability, efficacy, ease of use), established brand reputation, robust technical support, and guaranteed product consistency. These factors can sometimes justify a price premium for users prioritizing reliability and performance assurance. However, the significant price difference often makes generic versions a more economically viable choice for many end-users, especially in cost-sensitive agricultural markets.
Citations
[1] Global Agrochemical Market Report, Market Research Future. (n.d.). (Specific report details for Novaluron market sizing would be required here if available and publicly cited). [2] AgriChem Insights. (2023). Global Insecticide Market Analysis. [3] Chemical Industry Data Analysis. (2024). Active Ingredient Production Trends. [4] Crop Protection Council. (2022). Pesticide Registrations and Regulatory Landscape. [5] Veterinary Pharmaceutical News. (2023). Companion Animal Parasiticide Market Updates.
More… ↓
